| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,527 |
2,144 |
$58K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
866 |
753 |
$36K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
495 |
459 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
174 |
133 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
783 |
678 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
136 |
127 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
590 |
524 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
245 |
186 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
135 |
121 |
$2K |
| 80305 |
|
174 |
149 |
$1K |
| 86738 |
|
89 |
87 |
$1K |
| 81001 |
|
322 |
244 |
$675.23 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
31 |
$391.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
238 |
221 |
$147.26 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
72 |
70 |
$89.93 |
| 82043 |
|
12 |
12 |
$59.90 |
| 82570 |
|
12 |
12 |
$54.00 |
| 3074F |
|
212 |
196 |
$0.00 |
| 99080 |
|
433 |
383 |
$0.00 |
| 3078F |
|
140 |
133 |
$0.00 |